E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression

Molecular and Cellular Biology

Volumn 20, Issue 19, 2000, Pages 7059-7067

  Wu, L ^a   Goodwin, E C ^a   Naeger, L K ^a   Vigo, E ^a   Galaktionov, K ^a   Helin, K ^a   DiMaio, D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR E2F; VIRUS PROTEIN;

ARTICLE; COMPLEX FORMATION; GENE REPRESSION; HUMAN; HUMAN CELL; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS;

BINDING SITES; CARCINOMA, SQUAMOUS CELL; CDC25 PHOSPHATASE; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CERVIX NEOPLASMS; CONSENSUS SEQUENCE; CYSTEINE ENDOPEPTIDASES; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENES, RETINOBLASTOMA; HUMAN; MACROMOLECULAR SYSTEMS; MULTIENZYME COMPLEXES; NEOPLASM PROTEINS; PAPILLOMAVIRUS, BOVINE; PAPILLOMAVIRUS, HUMAN; PAPOVAVIRIDAE INFECTIONS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RETINOBLASTOMA PROTEIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS;

EID: 0033826257     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.19.7059-7067.2000     Document Type: Article

References (61)

1. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein
2. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes
3. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteosome pathway
4. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product
5. Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression
6. Cell cycle-specific association of E2F with the p130 E1A-binding protein
7. p53 point mutation in HPV-negative human cervical carcinoma cell lines
8. Distinct roles for E2F proteins in cell growth control and apoptosis
9. Cellular targets for activation by the E2FI transcription factor include DNA synthesis and G1/S regulatory genes
10. Abrogation of growth arrest signals by human papillomavirus type 16E7 is mediated by sequences required for transformation
11. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7
12. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis
13. Suppression of cellular proliferation by the papillomavirus E2 protein
14. Cdc25 protein phosphatases in cell proliferation
15. The regulation of E2F by pRB-family proteins
16. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
17. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells
18. Cdc25 cell-cycle phosphatase as a target of c-myc
19. E2F-4, a new member of the E2F transcription factor family, interacts with p107
20. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines
21. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene
22. Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins
23. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells
24. Cells expressing HPV16 E7 continue cycle progression following DNA damage-induced p53 activation
25. The interaction of Rb with E2F coincides with an inhibition of the transcriptional activity of E2F
26. The retinoblastoma gene product protects E2F1 from degradation by the ubiquitin-proteasome pathway
27. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter
28. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
29. Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene
30. Inhibition of cervical carcinoma cell line proliferation by introduction of a bovine papillomavirus regulatory gene
31. E2F and histone deacetylase mediate transforming growth factor [3 repression of cdc25A during keratinocyte cell cycle arrest
32. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation
33. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression
34. 1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein
35. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription
36. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor β through E2F binding sites
37. The subcellular localization of E2F-4 is cell-cycle dependent
38. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members
39. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry
40. An E2F-like repressor of transcription
41. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein
42. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-hinding sites within its promoter
43. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
44. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
45. 105 promoters
46. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
47. The HPV-16 E6 and EP-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
48. Cell cycle regulation of cyclin A gene transcription is mediated by a variant E2F binding site
49. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation
50. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein
51. 1 cell state
52. p130, p107, and pRB are differentially regulated in proliferating cells and during cell cycle arrest by α-interferon
53. In vivo structure of the human cdc2 promoter: Release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression
54. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members
55. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase
56. Human papillomaviruses and cervical cancer
57. Mechanism of active transcriptional repression by the retinoblastoma protein
58. Retinoblastoma protein switches the E2F site from positive to negative element
59. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoprotein
60. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation
61. Cell cycle regulation of E2F site occupation in vivo